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Background
The diagnostic criterion for beta thalassemia trait (BTT) is elevated Hb-A2 levels. Iron defi-
ciency anemia (IDA) reduces the synthesis of Hb-A2, resulting in reduced Hb-A2 levels, 
so patients with co-pathological conditions BTT with IDA, may have a normal level of 
Hb-A2. Many socio-economic factors like unawareness, poor diagnostic facilities, and 
cost of molecular diagnosis (for screening purposes) result in interpretation of these sub-
jects as normal.
Methods
Venous blood samples from 200 unmarried females having a family history of thalassemia 
were collected, and basic hematological parameters, hemoglobin electrophoresis, and 
molecular analysis for beta thalassemia were done. Patients with IDA and patients with 
co-pathological conditions BTT and IDA were treated with oral iron. These subjects were 
then followed for a period of 20 weeks. 
Results
Of the 200 females, 34 were found to be anemic. Hemoglobin electrophoresis identified 
16 of these patients as BTT. Molecular analysis of all patients confirmed this diagnosis, 
but identified 8 additional patients with BTT. Eight patients that were not detected with 
hemoglobin electrophoresis were found to have co-pathology of BTT with IDA.
Conclusion
Patients with the co-pathological condition BTT with IDA may be interpreted as being nor-
mal, as they have normal Hb-A2 levels. These misdiagnosed subjects when marry with 
BTT have the potential to produce beta thalassemia major in offspring. This is one of the 
factors playing a major role in the propagation of beta thalassemia gene in Pakistani pop-
ulation, and become a serious hindrance for the thalassemia prevention program in 
Pakistan.
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INTRODUCTION
  Clinical laboratory diagnosis is essential for therapeutic 
intervention in most diseases [1]. In this context, it is im-
portant to exclude interference by other conditions that may 
give false positive or false negative results, leading to in-
appropriate diagnosis [1, 2].
  Thalassemia is the most common genetic disorder world-
wide [3, 4]. To date, more than 200 causative molecular 
defects have been described in the beta globin gene causing 
beta thalassemia [5-7]. Beta thalassemia is the most common 
genetic disorder in Pakistan. Thirteen mutations are com-
monly reported in the Pakistani population, in which the 
5 most common mutations include IVS-I-5 (G→C), Codon 
8/9 (+G), Codon 41/42 (-TTCT), IVS-I-1 (G→T), and a 619-bp 
deletion [6, 8]. Thalassemia is a serious disease, requiring 
a preventive program based on the detection of the beta 
thalassemia trait (BTT) [8, 9]. Estimation of hemoglobin is 
important for the diagnosis of certain important clinical 
conditions. The diagnosis of BTT is based on elevation of 
Hb-A2 level (＞3.5%) [10-12].  
  Iron deficiency anemia (IDA) is the most common micro-
cytic hypochromic anemia world wide [13, 14]. Iron defi-
ciency modulates the synthesis of Hb-A2, resulting in reduced 
Hb-A2 levels in patients with IDA [15]. The normal Hb-A2 Korean J Hematol 2011;46:41-4.
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Fig. 1. Mutation bands of thalassemic genes in an agarose gel showing
Codon 41/42 (-TTCT) and Codon 8/9 (+G) and IVS1-5 (G→C). The 
Arabic numbers represent patient numbers. (A) 6a shows Codon 41/42
(-TTCT) and (B) 5 shows IVS1-5 (G→C) and 10, 11, 12, 14, 15 show 
Codon 8/9 (+G). M represents 50-bp-size marker.
Table 1. Molecular spectrum of beta thalassemia traits identified 
during this study.
Mutations Number of mutation observed
IVS-I-5 (G→C) 8 (33.33%)
Codon 8/9 (+G) 4 (16.7%)
Codon 41/42 (-TTCT) 6 (25%)
IVS-I-1 (G→T) 2 (8.33%)
619-bp deletion 2 (8.33%)
Codon 15 (G→A) 2 (8.33%)
Total mutations observed 24 (100%)
is composed of 2 alpha and 2 delta chains. The decreased 
Hb-A2 levels in iron deficiency could be due to decreased 
transcription and/or translation of the delta gene. Another 
possible explanation is competition between Hb-A beta 
chains and Hb-A2 delta chains in binding the limited quanti-
ties of available iron to their haem groups, as the ratio of 
beta: delta chains in normal RBC is 49：1 [16-18].
  The present study was designed to determine the role 
of the co-pathological condition, BTT with IDA in the mis-
diagnosis of beta thalassemia minor that may lead to child-
birth with transfusion-dependent beta thalassemia. This is 
an important risk factor involved in the propagation of the 
beta thalassemia gene in Pakistan.   
MATERIALS AND METHODS
  This multicenter study was conducted at the Baqai Institute 
of Hematology, Baqai Medical University and the Husaini 
Institute of Hematology and Oncology Trust, Karachi. Two 
hundred females aged 16 to 24 years (mean 18.5 years) and 
having a history of thalassemia in their families, were in-
cluded in this study. 
  Venous blood samples were collected into EDTA and basic 
hematological parameters, hemoglobin electrophoresis, and 
molecular analysis for beta thalassemia were done on all 
blood samples. Serum ferritin levels were done only on those 
samples that were not diagnosed as beta thalassemia minor 
on cellulose acetate hemoglobin electrophoresis, but were 
identified at the molecular level, and on samples of patients 
who were suspected of having IDA during this study.  
  Basic hematological parameters were performed using an 
automated analyzer (KX-21; Sysmex, Tokyo, Japan). Cellu-
lose acetate hemoglobin electrophoresis was done using a 
semi-automated technique (Interlab Roma Microtech Series 
# 648iso, Rome, Italy). 
  DNA was extracted from whole blood using the Genomic 
DNA Purification Kit (Gentra system, USA). For the de-
tection of beta thalassemia, the amplification refractory mu-
tation system (ARMS) technique was optimized. Thirteen 
pairs of primers (normal and mutant) were used for the 
detection of the beta thalassemia gene that has been pre-
viously reported in the Pakistani population [8]. ARMS pri-
mers were designed for the detection of both normal and 
mutant DNA. A control pair of primers was included in 
each assay. Control primers A, B, and C were amplified 
at 861-bp fragments from the 3' end of the β globin gene 
[5, 19, 20].
  PCR was conducted with a modified method in a mixture 
of 10 mmol/L TRIS (pH 8.3), 50 mM KCl, 1.5 mM MgCl2, 
500 μM each dNTP, 0.2 μM of each primer, 0.5 units of 
Thermus aquaticus (Taq) polymerase and 0.5 to 1 pg of ge-
nomic DNA in a total reaction volume of 20 μL. The modified 
cycling reaction (DNA thermal cycle; Perkin-Elmer/Cetus) 
was programmed at 94
oC for 1 minute, 65
oC for 1 minute 
and 72
oC for 1.5 minutes. After 25 cycles, the samples were 
incubated for additional 3 minutes at 66
oC [5, 19, 20]. The 
amplified PCR products were observed using agarose gel 
electrophoresis, and the mutation was characterized with 
100-bp or 50-bp ladder (Fig. 1).
  Patients with IDA and patients with the co-pathological 
condition BTT and IDA (both having low levels of serum 
ferritin) were treated with oral ferrous sulfate (325 mg/day). 
These subjects were then followed for a period of 20 weeks. 
Basic hematological parameters, hemoglobin electrophoresis 
and serum ferritin were performed on all treated subjects 
during and at the end of follow-up. Results were analyzed 
using SPSS statistical software version 17 (Chicago, IL, USA).  
RESULTS
  Two hundred unmarried females having a history of tha-
lassemia in their families were included in this study. Of 
these, 34 were found to be anemic. One of the types of 
anemia diagnosed was microcytic hypochromic based on 
red cell indices (MCV, MCH and MCHC). Among the 34 
anemic subjects, 16 were diagnosed as beta thalassemia minor Korean J Hematol 2011;46:41-4.
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Table 2. Comparison of basic hematological parameters, Hb-A2 and serum ferritin levels before and after treatment in patients with IDA and
patients with co-pathological condition (IDA+BTT).
Parameters
Patients with IDA Patients with co-pathological condition (IDA + BTT)
Before Tx After Tx P Before Tx After Tx P
Hb (g/dL) 9.4±0.4 12.7±0.8 0.001 8.9±0.2 11.5±0.5 0.002
RBC (×10
6/μL) 3.4±0.3 4.3±0.4 0.02 3.2±0.2 5.1±0.1 ＜0.001
MCV (fL) 64.8±3.1 77.4±2.4 0.001 64.0±2.9 67.0±2.6 0.005
MCH (pg) 22.6±1.6 28.1±1.1 0.001 22.1±1.4 25.1±1.7 0.050
MCHC (g %) 25.4±2.7 29.8±1.0 0.003 24.4±1.7 28.8±0.8 0.043
Hb-A2 (%) 1.7±0.1 2.9±0.3 0.001 2.6±0.6 5.2±0.3 ＜0.001
Serum ferritin (ng/mL) 2.91±1.2 29.8±7.1 ＜0.001 5.1±1.5 33.8±6.8 ＜0.001
Abbreviations: IDA, iron deficiency anemia; BTT, beta thalassemia trait;  Tx, treatment.
with the help of hemoglobin electrophoresis. Molecular anal-
ysis, performed in all patients, confirmed this diagnosis but 
identified 8 additional patients with BTT (Table 1). Eight 
patients, in which hemoglobin electrophoresis had failed 
to diagnose BTT, were found with a co-pathological con-
dition, i.e., BTT with IDA, as they have low levels of serum 
ferritin (Table 2). The 10 microcytic hypochromic anemic 
patients were diagnosed as IDA based on peripheral blood 
morphology and low levels of serum ferritin. The patients 
with IDA also showed low Hb-A2 levels.
  The 8 patients with the combined disorder BTT with IDA, 
who showed normal Hb-A2 levels before treatment, re-
sponded to oral iron therapy successfully and showed sig-
nificant increase in Hb-A2 levels. Patients with IDA only 
also responded to oral iron and their Hb-A2 levels were 
found to be normal at the end of the 20
th week of iron 
therapy (Table 2).
DISCUSSION
  Beta thalassemia and IDA are the most common micro-
cytic/hypochromic anemias in Pakistan. Pakistan has a pop-
ulation of 160 million people [21, 22]. The annual rate of 
population growth is 3% and almost 40% of the population 
is below 15 years of age [23]. There are 5 major ethnic 
groups Punjabi, Pathan, Sindhi, Baluchi and Urdu [6]. Each 
ethnic group is subdivided into Castes or ‘Biradris’ of people 
ranging from a few thousand to millions [22, 23]. There 
is a very strong tradition for people to marry within their 
Biradris. Marriage between close relatives, especially first 
cousins is a very common custom [22, 23]. 
  Beta thalassemia major is a fatal condition that only occurs 
when both parents are heterozygous for the beta thalassemic 
gene (beta thalassemia minor). Therefore, it is important 
to screen for beta thalassemia minor in the population to 
stop the propagation of the gene. In Pakistan, almost 6% 
of the population has the beta thalassemia gene (BTT) [23]. 
IDA is also the most common anemia in Pakistan, especially 
in females and young children [24, 25]. Thus, the chance 
of having a co-pathological condition, i.e., BTT with IDA 
is very high, and the result of this study revealed a high 
percentage of such cases.
  This study showed the presence of 5 common mutations 
IVS-1-5 (G→C), codon 8/9 (+G), codon 41/42 (-TTCT), 
IVS-1-1 (G→T) and 619-bp deletion with a frequency of 
91.66% in the Pakistani population. Usman et al. [6] also 
reported the presence of these 5 mutations with a frequency 
of 90% in the Pakistani population in a large number of samples 
(N=400), and proposed it as the basis of a prenatal program 
on a larger scale to stop the propagation of the beta thalasse-
mia gene. This is an important point that makes the thalasse-
mia prevention program, especially antenatal diagnosis, more 
affordable at the grass root level in Pakistan, but there is 
still no reduction in the rate of neonates with trans-
fusion-dependent beta thalassemia. This crucial fact demands 
re-thinking the factors that play a major role in the prop-
agation of the beta thalassemia gene. Therefore, this study 
was conducted to identify one of the very important factors 
that propagate the beta thalassemia gene in Pakistani 
population. The test population were unmarried females of 
childbearing age belong to families having a history of 
thalassemia. The diagnosis of beta thalassemia minor was 
based on elevated levels of Hb-A2, i.e., ＞3.5%. This study 
found 4 cases of BTT that were not diagnosed on Hb-electro-
phoresis, as they have normal levels of Hb-A2, but molecular 
analysis identified them as BTT. Further investigation re-
vealed that these patients have the co-pathological condition, 
BTT with IDA (as they have low levels of serum ferritin). 
These patients showed significant change in Hb-A2 levels 
after iron treatment.
  This important finding explains that iron deficiency causes 
a decrease in Hb-A2 levels, as these patients also have beta 
thalassemia minor, so elevated Hb-A2 levels after reduction 
became normal levels. This phenomenon is also strongly 
favored by patients with IDA, as they have low Hb-A 2 before 
treatment, but after treatment, they showed a significant 
rise in Hb-A2 levels. Thus, it is proved that iron deficiency 
caused significant lowering of Hb-A2 levels and the patients 
with the combined disorder BTT with IDA may show normal 
Hb-A2 levels.
  This fact is not negligible, as many factors such as the Korean J Hematol 2011;46:41-4.
44 Muhammad Usman, et al. 
lack of awareness among working pathologists and clinical 
consultants, poor facilities for diagnosis and expensive cost 
of molecular diagnosis (for screening purpose) may result 
in interpretation of these subjects as normal. These subjects, 
who may marry a man with BTT, may produce children 
with beta thalassemia major. This is the most important 
cause of the propagation of the beta thalassemia gene in 
the Pakistani population that becomes a serious hindrance 
for the thalassemia prevention program in Pakistan. To stop 
the propagation of the beta thalassemia gene through this 
mechanism, it is critical to identify cases of co-pathological 
conditions. No case of mild to moderate anemia suspected 
of having BTT based on hemoglobin electrophoresis will 
be reported as normal until the probability of iron deficiency 
is ruled out, especially in a country like Pakistan, where 
the rate of thalassemia minor is high and the etiology of 
IDA is common.
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